BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260411T065446
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:22101-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260411T065446
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:26544-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260411T065446
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:28159-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260411T065446
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:31242-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220520T110000
DTEND;TZID=America/Vancouver:20220520T120000
DTSTAMP:20260411T065446
CREATED:20220504T165341Z
LAST-MODIFIED:20220504T165341Z
UID:32702-1653044400-1653048000@scienceinvancouver.com
SUMMARY:Cancer Nanomedicine: Using Gold Nanoparticles to Overcome Radiotherapy Challenges
DESCRIPTION:Globally\, Cancer is the second leading cause of death. In 2018\, there were 18.1 million new cases worldwide and 9.5 million cancer-related deaths. By 2040\, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Approximately 50 percent of all cancer patients can benefit from radiotherapy (RT) in the management of their disease. Of these\, approximately half present early enough to pursue curative treatment approaches. \nThe major limitation to reaching a curative RT dose in high-risk (locally advanced) non-metastatic tumors is the high sensitivity to radiation and subsequent damage to the surrounding normal tissues. In an effort towards reducing side effects while increasing the damage to the tumour\, targeting of high atomic number materials such as gold nanoparticles (GNPs) as radiosensitizers to the tumour tissue has shown promising results. \nMoving forward\, understanding of the complex biological system present in and around the tumour is essential for optimizing the use of the radiosensitizing GNPs\, as outlined by a consortium of labs\, including my own. In this talk\, I will discuss the importance of using GNP-based novel strategies to overcome current challenges imposed by the tumour microenvironment. \n\n\n\n\n\n\nDr. Devika Chithrani is an associate professor in the Department of Physics and Astronomy at the University of Victoria\, Canada. She was awarded the faculty gold medal and the gold medal for physics when she received her bachelor’s degree (first class honors). To continue her graduate studies\, she was awarded a prestigious NSERC Graduate scholarship in materials science and engineering at University of Toronto. Following successful completion of her doctoral work\, she was awarded one of the most prestigious awards in Canada\, the NSERC PDF\, to continue her post-graduate research at the University of Toronto. \nDr. Chithrani now leverages nanotechnology to create innovations that advance the care of cancer patients. She is using gold nanoparticles as a radiation dose enhancer in cancer therapy. This work was featured on the cover of the journal Radiation Research and received the Michael S. Patterson publication award. She has developed three-dimensional tumor models to optimize bio-nano interface in cancer therapy. This work is featured on the cover of the journal Nano-Micro Letters. \nDr. Chithrani is considered one of the leaders in the field of nanotechnology and her publications have received over 10\,000 citations over the past 10 years. Her passion is to develop smart nanomaterials to improve exiting cancer therapeutics. She believes that many side effects due to chemotherapy can be reduced by controlled delivery of anticancer drugs using smart nanomaterials.
URL:https://scienceinvancouver.com/event/cancer-nanomedicine-using-gold-nanoparticles-to-overcome-radiotherapy-challenges-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220525T090000
DTEND;TZID=America/Vancouver:20220525T103000
DTSTAMP:20260411T065446
CREATED:20220516T035859Z
LAST-MODIFIED:20220516T035859Z
UID:22227-1653469200-1653474600@scienceinvancouver.com
SUMMARY:Neuroscience and Neurotechnology Seminar Series
DESCRIPTION:SFU’s Institute for Neuroscience and Neurotechnology (INN) invites you to a virtual seminar on May 25\, 2022 at 9am PDT . \nTopic: Virtual Brain Cloud: Enabling Complex Simulations with Multilevel Health Data \nSpeaker: Dr. Petra Ritter\, Professor\, Department of Neurology and Experimental Neurology\, Charité – Universitätsmedizin Berlin \nAbstract: Virtual Brain Cloud generates multilevel virtual brains of patients and healthy human controls for research and innovation. Brain data from multiple sources are being pre-processed and annotated with a common data model – such that they all relate to common spatial reference frameworks. The platform thus offers a next generation clinical research infrastructure – compliant with Data Protection Regulations and creates an open yet protected space for groundbreaking digital health innovation. \nFor more information\, or to register without using Eventbrite\, please email inn@sfu.ca
URL:https://scienceinvancouver.com/event/neuroscience-and-neurotechnology-seminar-series/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220525T090000
DTEND;TZID=America/Vancouver:20220525T103000
DTSTAMP:20260411T065446
CREATED:20220516T035859Z
LAST-MODIFIED:20220516T035859Z
UID:26550-1653469200-1653474600@scienceinvancouver.com
SUMMARY:Neuroscience and Neurotechnology Seminar Series
DESCRIPTION:SFU’s Institute for Neuroscience and Neurotechnology (INN) invites you to a virtual seminar on May 25\, 2022 at 9am PDT . \nTopic: Virtual Brain Cloud: Enabling Complex Simulations with Multilevel Health Data \nSpeaker: Dr. Petra Ritter\, Professor\, Department of Neurology and Experimental Neurology\, Charité – Universitätsmedizin Berlin \nAbstract: Virtual Brain Cloud generates multilevel virtual brains of patients and healthy human controls for research and innovation. Brain data from multiple sources are being pre-processed and annotated with a common data model – such that they all relate to common spatial reference frameworks. The platform thus offers a next generation clinical research infrastructure – compliant with Data Protection Regulations and creates an open yet protected space for groundbreaking digital health innovation. \nFor more information\, or to register without using Eventbrite\, please email inn@sfu.ca
URL:https://scienceinvancouver.com/event/neuroscience-and-neurotechnology-seminar-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220525T090000
DTEND;TZID=America/Vancouver:20220525T103000
DTSTAMP:20260411T065446
CREATED:20220516T035859Z
LAST-MODIFIED:20220516T035859Z
UID:28165-1653469200-1653474600@scienceinvancouver.com
SUMMARY:Neuroscience and Neurotechnology Seminar Series
DESCRIPTION:SFU’s Institute for Neuroscience and Neurotechnology (INN) invites you to a virtual seminar on May 25\, 2022 at 9am PDT . \nTopic: Virtual Brain Cloud: Enabling Complex Simulations with Multilevel Health Data \nSpeaker: Dr. Petra Ritter\, Professor\, Department of Neurology and Experimental Neurology\, Charité – Universitätsmedizin Berlin \nAbstract: Virtual Brain Cloud generates multilevel virtual brains of patients and healthy human controls for research and innovation. Brain data from multiple sources are being pre-processed and annotated with a common data model – such that they all relate to common spatial reference frameworks. The platform thus offers a next generation clinical research infrastructure – compliant with Data Protection Regulations and creates an open yet protected space for groundbreaking digital health innovation. \nFor more information\, or to register without using Eventbrite\, please email inn@sfu.ca
URL:https://scienceinvancouver.com/event/neuroscience-and-neurotechnology-seminar-series-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220525T090000
DTEND;TZID=America/Vancouver:20220525T103000
DTSTAMP:20260411T065446
CREATED:20220516T035859Z
LAST-MODIFIED:20220516T035859Z
UID:31248-1653469200-1653474600@scienceinvancouver.com
SUMMARY:Neuroscience and Neurotechnology Seminar Series
DESCRIPTION:SFU’s Institute for Neuroscience and Neurotechnology (INN) invites you to a virtual seminar on May 25\, 2022 at 9am PDT . \nTopic: Virtual Brain Cloud: Enabling Complex Simulations with Multilevel Health Data \nSpeaker: Dr. Petra Ritter\, Professor\, Department of Neurology and Experimental Neurology\, Charité – Universitätsmedizin Berlin \nAbstract: Virtual Brain Cloud generates multilevel virtual brains of patients and healthy human controls for research and innovation. Brain data from multiple sources are being pre-processed and annotated with a common data model – such that they all relate to common spatial reference frameworks. The platform thus offers a next generation clinical research infrastructure – compliant with Data Protection Regulations and creates an open yet protected space for groundbreaking digital health innovation. \nFor more information\, or to register without using Eventbrite\, please email inn@sfu.ca
URL:https://scienceinvancouver.com/event/neuroscience-and-neurotechnology-seminar-series-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220525T090000
DTEND;TZID=America/Vancouver:20220525T103000
DTSTAMP:20260411T065446
CREATED:20220516T035859Z
LAST-MODIFIED:20220516T035859Z
UID:32708-1653469200-1653474600@scienceinvancouver.com
SUMMARY:Neuroscience and Neurotechnology Seminar Series
DESCRIPTION:SFU’s Institute for Neuroscience and Neurotechnology (INN) invites you to a virtual seminar on May 25\, 2022 at 9am PDT . \nTopic: Virtual Brain Cloud: Enabling Complex Simulations with Multilevel Health Data \nSpeaker: Dr. Petra Ritter\, Professor\, Department of Neurology and Experimental Neurology\, Charité – Universitätsmedizin Berlin \nAbstract: Virtual Brain Cloud generates multilevel virtual brains of patients and healthy human controls for research and innovation. Brain data from multiple sources are being pre-processed and annotated with a common data model – such that they all relate to common spatial reference frameworks. The platform thus offers a next generation clinical research infrastructure – compliant with Data Protection Regulations and creates an open yet protected space for groundbreaking digital health innovation. \nFor more information\, or to register without using Eventbrite\, please email inn@sfu.ca
URL:https://scienceinvancouver.com/event/neuroscience-and-neurotechnology-seminar-series-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220527T011000
DTEND;TZID=America/Vancouver:20220527T110000
DTSTAMP:20260411T065446
CREATED:20220404T022809Z
LAST-MODIFIED:20220516T214518Z
UID:21524-1653613800-1653649200@scienceinvancouver.com
SUMMARY:PathDay 2022
DESCRIPTION:PathDay will be held in person May 27\, 2022 at the  Holiday Inn\, 711 W. Broadway @ Heather St\, Vancouver\, BC V5Z 3Y2. The organizers have their fingers crossed to host an in-person conference\, however there might be some virtual components. \n\n\nKeynote speaker: Dr. Ralph Hruban \nTitle: “The World is Not Flat! A “Clearer” Three-dimensional View of Pancreatic Cancer” \nDr. Hruban’s Bio \n\n\n\nJames Hogg Lecturer: Dr. Dana Devine \nTitle: “The Impact of Blood Donor Variation on Transfusion Product Quality” [lecture via live Zoom broadcast] \nDr. Devine’s Bio \n\n\n\nGuest speaker: Dr. Naveena Singh \nTitle: “The Shifting Landscape of Endometrial Carcinoma” \nDr. Singh’s Bio \n\n\n\nGuest speaker: Dr. Natalie Prystajecky \nTitle: TBA – This talk will be COVID/Public Health related. \nDr. Prystajecky’s Bio
URL:https://scienceinvancouver.com/event/pathday-2022/
LOCATION:Holiday Inn\, 711 W. Broadway\, Vancouver\, BC\, V5Z 3Y2\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220527T011000
DTEND;TZID=America/Vancouver:20220527T110000
DTSTAMP:20260411T065446
CREATED:20220404T022809Z
LAST-MODIFIED:20220404T022809Z
UID:26531-1653613800-1653649200@scienceinvancouver.com
SUMMARY:PathDay 2022
DESCRIPTION:PathDay will be held in person May 27\, 2022 at the  Holiday Inn\, 711 W. Broadway @ Heather St\, Vancouver\, BC V5Z 3Y2. The organizers have their fingers crossed to host an in-person conference\, however there might be some virtual components. \n\n\nKeynote speaker: Dr. Ralph Hruban \nTitle: “The World is Not Flat! A “Clearer” Three-dimensional View of Pancreatic Cancer” \nDr. Hruban’s Bio \n\n\n\nJames Hogg Lecturer: Dr. Dana Devine \nTitle: “The Impact of Blood Donor Variation on Transfusion Product Quality” [lecture via live Zoom broadcast] \nDr. Devine’s Bio \n\n\n\nGuest speaker: Dr. Naveena Singh \nTitle: “The Shifting Landscape of Endometrial Carcinoma” \nDr. Singh’s Bio \n\n\n\nGuest speaker: Dr. Natalie Prystajecky \nTitle: TBA – This talk will be COVID/Public Health related. \nDr. Prystajecky’s Bio
URL:https://scienceinvancouver.com/event/pathday-2022-2/
LOCATION:Holiday Inn\, 711 W. Broadway\, Vancouver\, BC\, V5Z 3Y2\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220527T011000
DTEND;TZID=America/Vancouver:20220527T110000
DTSTAMP:20260411T065446
CREATED:20220404T022809Z
LAST-MODIFIED:20220404T022809Z
UID:28146-1653613800-1653649200@scienceinvancouver.com
SUMMARY:PathDay 2022
DESCRIPTION:PathDay will be held in person May 27\, 2022 at the  Holiday Inn\, 711 W. Broadway @ Heather St\, Vancouver\, BC V5Z 3Y2. The organizers have their fingers crossed to host an in-person conference\, however there might be some virtual components. \n\n\nKeynote speaker: Dr. Ralph Hruban \nTitle: “The World is Not Flat! A “Clearer” Three-dimensional View of Pancreatic Cancer” \nDr. Hruban’s Bio \n\n\n\nJames Hogg Lecturer: Dr. Dana Devine \nTitle: “The Impact of Blood Donor Variation on Transfusion Product Quality” [lecture via live Zoom broadcast] \nDr. Devine’s Bio \n\n\n\nGuest speaker: Dr. Naveena Singh \nTitle: “The Shifting Landscape of Endometrial Carcinoma” \nDr. Singh’s Bio \n\n\n\nGuest speaker: Dr. Natalie Prystajecky \nTitle: TBA – This talk will be COVID/Public Health related. \nDr. Prystajecky’s Bio
URL:https://scienceinvancouver.com/event/pathday-2022-3/
LOCATION:Holiday Inn\, 711 W. Broadway\, Vancouver\, BC\, V5Z 3Y2\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220527T011000
DTEND;TZID=America/Vancouver:20220527T110000
DTSTAMP:20260411T065446
CREATED:20220404T022809Z
LAST-MODIFIED:20220404T022809Z
UID:31229-1653613800-1653649200@scienceinvancouver.com
SUMMARY:PathDay 2022
DESCRIPTION:PathDay will be held in person May 27\, 2022 at the  Holiday Inn\, 711 W. Broadway @ Heather St\, Vancouver\, BC V5Z 3Y2. The organizers have their fingers crossed to host an in-person conference\, however there might be some virtual components. \n\n\nKeynote speaker: Dr. Ralph Hruban \nTitle: “The World is Not Flat! A “Clearer” Three-dimensional View of Pancreatic Cancer” \nDr. Hruban’s Bio \n\n\n\nJames Hogg Lecturer: Dr. Dana Devine \nTitle: “The Impact of Blood Donor Variation on Transfusion Product Quality” [lecture via live Zoom broadcast] \nDr. Devine’s Bio \n\n\n\nGuest speaker: Dr. Naveena Singh \nTitle: “The Shifting Landscape of Endometrial Carcinoma” \nDr. Singh’s Bio \n\n\n\nGuest speaker: Dr. Natalie Prystajecky \nTitle: TBA – This talk will be COVID/Public Health related. \nDr. Prystajecky’s Bio
URL:https://scienceinvancouver.com/event/pathday-2022-4/
LOCATION:Holiday Inn\, 711 W. Broadway\, Vancouver\, BC\, V5Z 3Y2\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220527T011000
DTEND;TZID=America/Vancouver:20220527T110000
DTSTAMP:20260411T065446
CREATED:20220404T022809Z
LAST-MODIFIED:20220404T022809Z
UID:32689-1653613800-1653649200@scienceinvancouver.com
SUMMARY:PathDay 2022
DESCRIPTION:PathDay will be held in person May 27\, 2022 at the  Holiday Inn\, 711 W. Broadway @ Heather St\, Vancouver\, BC V5Z 3Y2. The organizers have their fingers crossed to host an in-person conference\, however there might be some virtual components. \n\n\nKeynote speaker: Dr. Ralph Hruban \nTitle: “The World is Not Flat! A “Clearer” Three-dimensional View of Pancreatic Cancer” \nDr. Hruban’s Bio \n\n\n\nJames Hogg Lecturer: Dr. Dana Devine \nTitle: “The Impact of Blood Donor Variation on Transfusion Product Quality” [lecture via live Zoom broadcast] \nDr. Devine’s Bio \n\n\n\nGuest speaker: Dr. Naveena Singh \nTitle: “The Shifting Landscape of Endometrial Carcinoma” \nDr. Singh’s Bio \n\n\n\nGuest speaker: Dr. Natalie Prystajecky \nTitle: TBA – This talk will be COVID/Public Health related. \nDr. Prystajecky’s Bio
URL:https://scienceinvancouver.com/event/pathday-2022-5/
LOCATION:Holiday Inn\, 711 W. Broadway\, Vancouver\, BC\, V5Z 3Y2\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220530T120000
DTEND;TZID=America/Vancouver:20220530T133000
DTSTAMP:20260411T065446
CREATED:20220513T220902Z
LAST-MODIFIED:20220524T072624Z
UID:22215-1653912000-1653917400@scienceinvancouver.com
SUMMARY:2022 Varshney Visiting Scholar Public Lecture – Dr. Prabhakaran Dorairaj – the Right Diet and Lifestyle for a Healthy Heart
DESCRIPTION:Abstract\nHeart diseases\, diabetes and their risk factors are the leading cause of death and disability worldwide. Some ethnicities such as South Asians have high propensity to develop heart diseases and diabetes as compared to other populations. These diseases are potentially preventable or can be postponed to an older age so that premature death can be avoided by following the right lifestyle and diet. However tremendous confusion abounds regarding the right diet. This talk will clarify the right diet and lifestyle for a health heart. \nBio\nProfessor Prabhakaran Dorairaj is an internationally renowned cardiologist\, epidemiologist and researcher. His initial training was from the prestigious All India Institute of Medical Sciences and McMaster University. He is currently the Vice President-Research & Policy\, Public Health Foundation of India; Executive Director of the Centre for Chronic Disease Control\, New Delhi\, India; and Professor (Epidemiology) at the London School of Hygiene and Tropical Medicine\, UK\, with multiple visiting professor appointments including Harvard School of Public Health\, McMaster and Emory Universities. Recognising his contribution to Indian Science\, he was elected as a Fellow of the Indian National Science Academy\, the highest science academy of India. His work has led to understanding the underlying mechanisms for the high propensity of diabetes and heart disease among Indians. \nDr. Prabhakaran Dorairaj is a Visiting Professor in the Faculty of Health Sciences at SFU\, and his appointment here was made possible through the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies. \nAbout the Varshney Visiting Scholars Program\nThe Visiting Scholars Program in Indian Studies was first established by Simon Fraser University and the Indian Council for Cultural Relations (ICCR) and was named the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies in recognition of the Varshney’s generous investment. The program will foster and strengthen cultural relations by hosting world-class Indian scholars from a wide range of disciplines such as international studies\, contemporary arts\, business and world literature. \nThis public lecture is organized by SFU’s Faculty of Health Sciences and funded through an endowment provided by the Hari and Madhu Varshney Visiting Scholar in Indian Studies program. \nAttend in person or online\nDoors Open: 6:30pm\nLecture and Q&A: 7:00-8:30pm\nLight refreshments will be served before and after the lecture. \nThere are a limited number of tickets to attend in person at the Fletcher Challenge Canada Theatre (Room 1900) at SFU Harbour Centre. \nThis lecture will also be livestreamed on YouTube for online audiences. A link to access the livestream will be available here before the event.
URL:https://scienceinvancouver.com/event/2022-varshney-visiting-scholar-public-lecture-dr-prabhakaran-dorairaj-the-right-diet-and-lifestyle-for-a-healthy-heart/
LOCATION:SFU Harbour Centre\, 515 W Hastings St\, Vancouver\, British Columbia\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220530T120000
DTEND;TZID=America/Vancouver:20220530T133000
DTSTAMP:20260411T065446
CREATED:20220513T220902Z
LAST-MODIFIED:20220513T220902Z
UID:26549-1653912000-1653917400@scienceinvancouver.com
SUMMARY:2022 Varshney Visiting Scholar Public Lecture – Dr. Prabhakaran Dorairaj – the Right Diet and Lifestyle for a Healthy Heart
DESCRIPTION:Abstract\nHeart diseases\, diabetes and their risk factors are the leading cause of death and disability worldwide. Some ethnicities such as South Asians have high propensity to develop heart diseases and diabetes as compared to other populations. These diseases are potentially preventable or can be postponed to an older age so that premature death can be avoided by following the right lifestyle and diet. However tremendous confusion abounds regarding the right diet. This talk will clarify the right diet and lifestyle for a health heart. \nBio\nProfessor Prabhakaran Dorairaj is an internationally renowned cardiologist\, epidemiologist and researcher. His initial training was from the prestigious All India Institute of Medical Sciences and McMaster University. He is currently the Vice President-Research & Policy\, Public Health Foundation of India; Executive Director of the Centre for Chronic Disease Control\, New Delhi\, India; and Professor (Epidemiology) at the London School of Hygiene and Tropical Medicine\, UK\, with multiple visiting professor appointments including Harvard School of Public Health\, McMaster and Emory Universities. Recognising his contribution to Indian Science\, he was elected as a Fellow of the Indian National Science Academy\, the highest science academy of India. His work has led to understanding the underlying mechanisms for the high propensity of diabetes and heart disease among Indians. \nDr. Prabhakaran Dorairaj is a Visiting Professor in the Faculty of Health Sciences at SFU\, and his appointment here was made possible through the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies. \nAbout the Varshney Visiting Scholars Program\nThe Visiting Scholars Program in Indian Studies was first established by Simon Fraser University and the Indian Council for Cultural Relations (ICCR) and was named the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies in recognition of the Varshney’s generous investment. The program will foster and strengthen cultural relations by hosting world-class Indian scholars from a wide range of disciplines such as international studies\, contemporary arts\, business and world literature. \nThis public lecture is organized by SFU’s Faculty of Health Sciences and funded through an endowment provided by the Hari and Madhu Varshney Visiting Scholar in Indian Studies program. \nAttend in person or online\nDoors Open: 6:30pm\nLecture and Q&A: 7:00-8:30pm\nLight refreshments will be served before and after the lecture. \nThere are a limited number of tickets to attend in person at the Fletcher Challenge Canada Theatre (Room 1900) at SFU Harbour Centre. \nThis lecture will also be livestreamed on YouTube for online audiences. A link to access the livestream will be available here before the event.
URL:https://scienceinvancouver.com/event/2022-varshney-visiting-scholar-public-lecture-dr-prabhakaran-dorairaj-the-right-diet-and-lifestyle-for-a-healthy-heart-2/
LOCATION:SFU Harbour Centre\, 515 W Hastings St\, Vancouver\, British Columbia\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220530T120000
DTEND;TZID=America/Vancouver:20220530T133000
DTSTAMP:20260411T065446
CREATED:20220513T220902Z
LAST-MODIFIED:20220513T220902Z
UID:28164-1653912000-1653917400@scienceinvancouver.com
SUMMARY:2022 Varshney Visiting Scholar Public Lecture – Dr. Prabhakaran Dorairaj – the Right Diet and Lifestyle for a Healthy Heart
DESCRIPTION:Abstract\nHeart diseases\, diabetes and their risk factors are the leading cause of death and disability worldwide. Some ethnicities such as South Asians have high propensity to develop heart diseases and diabetes as compared to other populations. These diseases are potentially preventable or can be postponed to an older age so that premature death can be avoided by following the right lifestyle and diet. However tremendous confusion abounds regarding the right diet. This talk will clarify the right diet and lifestyle for a health heart. \nBio\nProfessor Prabhakaran Dorairaj is an internationally renowned cardiologist\, epidemiologist and researcher. His initial training was from the prestigious All India Institute of Medical Sciences and McMaster University. He is currently the Vice President-Research & Policy\, Public Health Foundation of India; Executive Director of the Centre for Chronic Disease Control\, New Delhi\, India; and Professor (Epidemiology) at the London School of Hygiene and Tropical Medicine\, UK\, with multiple visiting professor appointments including Harvard School of Public Health\, McMaster and Emory Universities. Recognising his contribution to Indian Science\, he was elected as a Fellow of the Indian National Science Academy\, the highest science academy of India. His work has led to understanding the underlying mechanisms for the high propensity of diabetes and heart disease among Indians. \nDr. Prabhakaran Dorairaj is a Visiting Professor in the Faculty of Health Sciences at SFU\, and his appointment here was made possible through the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies. \nAbout the Varshney Visiting Scholars Program\nThe Visiting Scholars Program in Indian Studies was first established by Simon Fraser University and the Indian Council for Cultural Relations (ICCR) and was named the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies in recognition of the Varshney’s generous investment. The program will foster and strengthen cultural relations by hosting world-class Indian scholars from a wide range of disciplines such as international studies\, contemporary arts\, business and world literature. \nThis public lecture is organized by SFU’s Faculty of Health Sciences and funded through an endowment provided by the Hari and Madhu Varshney Visiting Scholar in Indian Studies program. \nAttend in person or online\nDoors Open: 6:30pm\nLecture and Q&A: 7:00-8:30pm\nLight refreshments will be served before and after the lecture. \nThere are a limited number of tickets to attend in person at the Fletcher Challenge Canada Theatre (Room 1900) at SFU Harbour Centre. \nThis lecture will also be livestreamed on YouTube for online audiences. A link to access the livestream will be available here before the event.
URL:https://scienceinvancouver.com/event/2022-varshney-visiting-scholar-public-lecture-dr-prabhakaran-dorairaj-the-right-diet-and-lifestyle-for-a-healthy-heart-3/
LOCATION:SFU Harbour Centre\, 515 W Hastings St\, Vancouver\, British Columbia\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220530T120000
DTEND;TZID=America/Vancouver:20220530T133000
DTSTAMP:20260411T065446
CREATED:20220513T220902Z
LAST-MODIFIED:20220513T220902Z
UID:31247-1653912000-1653917400@scienceinvancouver.com
SUMMARY:2022 Varshney Visiting Scholar Public Lecture – Dr. Prabhakaran Dorairaj – the Right Diet and Lifestyle for a Healthy Heart
DESCRIPTION:Abstract\nHeart diseases\, diabetes and their risk factors are the leading cause of death and disability worldwide. Some ethnicities such as South Asians have high propensity to develop heart diseases and diabetes as compared to other populations. These diseases are potentially preventable or can be postponed to an older age so that premature death can be avoided by following the right lifestyle and diet. However tremendous confusion abounds regarding the right diet. This talk will clarify the right diet and lifestyle for a health heart. \nBio\nProfessor Prabhakaran Dorairaj is an internationally renowned cardiologist\, epidemiologist and researcher. His initial training was from the prestigious All India Institute of Medical Sciences and McMaster University. He is currently the Vice President-Research & Policy\, Public Health Foundation of India; Executive Director of the Centre for Chronic Disease Control\, New Delhi\, India; and Professor (Epidemiology) at the London School of Hygiene and Tropical Medicine\, UK\, with multiple visiting professor appointments including Harvard School of Public Health\, McMaster and Emory Universities. Recognising his contribution to Indian Science\, he was elected as a Fellow of the Indian National Science Academy\, the highest science academy of India. His work has led to understanding the underlying mechanisms for the high propensity of diabetes and heart disease among Indians. \nDr. Prabhakaran Dorairaj is a Visiting Professor in the Faculty of Health Sciences at SFU\, and his appointment here was made possible through the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies. \nAbout the Varshney Visiting Scholars Program\nThe Visiting Scholars Program in Indian Studies was first established by Simon Fraser University and the Indian Council for Cultural Relations (ICCR) and was named the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies in recognition of the Varshney’s generous investment. The program will foster and strengthen cultural relations by hosting world-class Indian scholars from a wide range of disciplines such as international studies\, contemporary arts\, business and world literature. \nThis public lecture is organized by SFU’s Faculty of Health Sciences and funded through an endowment provided by the Hari and Madhu Varshney Visiting Scholar in Indian Studies program. \nAttend in person or online\nDoors Open: 6:30pm\nLecture and Q&A: 7:00-8:30pm\nLight refreshments will be served before and after the lecture. \nThere are a limited number of tickets to attend in person at the Fletcher Challenge Canada Theatre (Room 1900) at SFU Harbour Centre. \nThis lecture will also be livestreamed on YouTube for online audiences. A link to access the livestream will be available here before the event.
URL:https://scienceinvancouver.com/event/2022-varshney-visiting-scholar-public-lecture-dr-prabhakaran-dorairaj-the-right-diet-and-lifestyle-for-a-healthy-heart-4/
LOCATION:SFU Harbour Centre\, 515 W Hastings St\, Vancouver\, British Columbia\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220530T120000
DTEND;TZID=America/Vancouver:20220530T133000
DTSTAMP:20260411T065446
CREATED:20220513T220902Z
LAST-MODIFIED:20220513T220902Z
UID:32707-1653912000-1653917400@scienceinvancouver.com
SUMMARY:2022 Varshney Visiting Scholar Public Lecture – Dr. Prabhakaran Dorairaj – the Right Diet and Lifestyle for a Healthy Heart
DESCRIPTION:Abstract\nHeart diseases\, diabetes and their risk factors are the leading cause of death and disability worldwide. Some ethnicities such as South Asians have high propensity to develop heart diseases and diabetes as compared to other populations. These diseases are potentially preventable or can be postponed to an older age so that premature death can be avoided by following the right lifestyle and diet. However tremendous confusion abounds regarding the right diet. This talk will clarify the right diet and lifestyle for a health heart. \nBio\nProfessor Prabhakaran Dorairaj is an internationally renowned cardiologist\, epidemiologist and researcher. His initial training was from the prestigious All India Institute of Medical Sciences and McMaster University. He is currently the Vice President-Research & Policy\, Public Health Foundation of India; Executive Director of the Centre for Chronic Disease Control\, New Delhi\, India; and Professor (Epidemiology) at the London School of Hygiene and Tropical Medicine\, UK\, with multiple visiting professor appointments including Harvard School of Public Health\, McMaster and Emory Universities. Recognising his contribution to Indian Science\, he was elected as a Fellow of the Indian National Science Academy\, the highest science academy of India. His work has led to understanding the underlying mechanisms for the high propensity of diabetes and heart disease among Indians. \nDr. Prabhakaran Dorairaj is a Visiting Professor in the Faculty of Health Sciences at SFU\, and his appointment here was made possible through the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies. \nAbout the Varshney Visiting Scholars Program\nThe Visiting Scholars Program in Indian Studies was first established by Simon Fraser University and the Indian Council for Cultural Relations (ICCR) and was named the Hari and Madhu Varshney Visiting Scholars Program in Indian Studies in recognition of the Varshney’s generous investment. The program will foster and strengthen cultural relations by hosting world-class Indian scholars from a wide range of disciplines such as international studies\, contemporary arts\, business and world literature. \nThis public lecture is organized by SFU’s Faculty of Health Sciences and funded through an endowment provided by the Hari and Madhu Varshney Visiting Scholar in Indian Studies program. \nAttend in person or online\nDoors Open: 6:30pm\nLecture and Q&A: 7:00-8:30pm\nLight refreshments will be served before and after the lecture. \nThere are a limited number of tickets to attend in person at the Fletcher Challenge Canada Theatre (Room 1900) at SFU Harbour Centre. \nThis lecture will also be livestreamed on YouTube for online audiences. A link to access the livestream will be available here before the event.
URL:https://scienceinvancouver.com/event/2022-varshney-visiting-scholar-public-lecture-dr-prabhakaran-dorairaj-the-right-diet-and-lifestyle-for-a-healthy-heart-5/
LOCATION:SFU Harbour Centre\, 515 W Hastings St\, Vancouver\, British Columbia\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20260411T065446
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:22104-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20260411T065446
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:26545-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20260411T065446
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:28160-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20260411T065446
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:31243-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20260411T065446
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:32703-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220601T120000
DTEND;TZID=America/Vancouver:20220601T130000
DTSTAMP:20260411T065446
CREATED:20220530T180740Z
LAST-MODIFIED:20220530T180740Z
UID:22501-1654084800-1654088400@scienceinvancouver.com
SUMMARY:BC-CfE Celebrates 30 Years of Excellence
DESCRIPTION:Learning Series Event \nAudience: General Public \nWednesday\, June 1\, 2022\, 12:00 pm – 1:00 pm\nLocation: Register online at: https://register.gotowebinar.com/register/6143407294263777294 \nCost: Free registration. \nFEATURING: \nPeter Phillips\nClinical Professor\nDivision of Infectious Diseases\nUniversity of British Columbia \n\nTune in as BC-CfE Director of Clinical Education Dr. Val Montessori and Clinical Professor\, Dr. Peter Phillips\, talk early days\, and what it was like treating the earliest cases of HIV. \nPlease register for the webinar by clicking the following link: \nCLICK HERE. \n*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars \nIf you have any questions regarding this event\, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. \nDOWNLOAD POSTER PDF
URL:https://scienceinvancouver.com/event/bc-cfe-celebrates-30-years-of-excellence/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220601T120000
DTEND;TZID=America/Vancouver:20220601T130000
DTSTAMP:20260411T065446
CREATED:20220530T180740Z
LAST-MODIFIED:20220530T180740Z
UID:26554-1654084800-1654088400@scienceinvancouver.com
SUMMARY:BC-CfE Celebrates 30 Years of Excellence
DESCRIPTION:Learning Series Event \nAudience: General Public \nWednesday\, June 1\, 2022\, 12:00 pm – 1:00 pm\nLocation: Register online at: https://register.gotowebinar.com/register/6143407294263777294 \nCost: Free registration. \nFEATURING: \nPeter Phillips\nClinical Professor\nDivision of Infectious Diseases\nUniversity of British Columbia \n\nTune in as BC-CfE Director of Clinical Education Dr. Val Montessori and Clinical Professor\, Dr. Peter Phillips\, talk early days\, and what it was like treating the earliest cases of HIV. \nPlease register for the webinar by clicking the following link: \nCLICK HERE. \n*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars \nIf you have any questions regarding this event\, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. \nDOWNLOAD POSTER PDF
URL:https://scienceinvancouver.com/event/bc-cfe-celebrates-30-years-of-excellence-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220601T120000
DTEND;TZID=America/Vancouver:20220601T130000
DTSTAMP:20260411T065446
CREATED:20220530T180740Z
LAST-MODIFIED:20220530T180740Z
UID:28169-1654084800-1654088400@scienceinvancouver.com
SUMMARY:BC-CfE Celebrates 30 Years of Excellence
DESCRIPTION:Learning Series Event \nAudience: General Public \nWednesday\, June 1\, 2022\, 12:00 pm – 1:00 pm\nLocation: Register online at: https://register.gotowebinar.com/register/6143407294263777294 \nCost: Free registration. \nFEATURING: \nPeter Phillips\nClinical Professor\nDivision of Infectious Diseases\nUniversity of British Columbia \n\nTune in as BC-CfE Director of Clinical Education Dr. Val Montessori and Clinical Professor\, Dr. Peter Phillips\, talk early days\, and what it was like treating the earliest cases of HIV. \nPlease register for the webinar by clicking the following link: \nCLICK HERE. \n*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars \nIf you have any questions regarding this event\, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. \nDOWNLOAD POSTER PDF
URL:https://scienceinvancouver.com/event/bc-cfe-celebrates-30-years-of-excellence-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220601T120000
DTEND;TZID=America/Vancouver:20220601T130000
DTSTAMP:20260411T065446
CREATED:20220530T180740Z
LAST-MODIFIED:20220530T180740Z
UID:31252-1654084800-1654088400@scienceinvancouver.com
SUMMARY:BC-CfE Celebrates 30 Years of Excellence
DESCRIPTION:Learning Series Event \nAudience: General Public \nWednesday\, June 1\, 2022\, 12:00 pm – 1:00 pm\nLocation: Register online at: https://register.gotowebinar.com/register/6143407294263777294 \nCost: Free registration. \nFEATURING: \nPeter Phillips\nClinical Professor\nDivision of Infectious Diseases\nUniversity of British Columbia \n\nTune in as BC-CfE Director of Clinical Education Dr. Val Montessori and Clinical Professor\, Dr. Peter Phillips\, talk early days\, and what it was like treating the earliest cases of HIV. \nPlease register for the webinar by clicking the following link: \nCLICK HERE. \n*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars \nIf you have any questions regarding this event\, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. \nDOWNLOAD POSTER PDF
URL:https://scienceinvancouver.com/event/bc-cfe-celebrates-30-years-of-excellence-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220601T120000
DTEND;TZID=America/Vancouver:20220601T130000
DTSTAMP:20260411T065446
CREATED:20220530T180740Z
LAST-MODIFIED:20220530T180740Z
UID:32712-1654084800-1654088400@scienceinvancouver.com
SUMMARY:BC-CfE Celebrates 30 Years of Excellence
DESCRIPTION:Learning Series Event \nAudience: General Public \nWednesday\, June 1\, 2022\, 12:00 pm – 1:00 pm\nLocation: Register online at: https://register.gotowebinar.com/register/6143407294263777294 \nCost: Free registration. \nFEATURING: \nPeter Phillips\nClinical Professor\nDivision of Infectious Diseases\nUniversity of British Columbia \n\nTune in as BC-CfE Director of Clinical Education Dr. Val Montessori and Clinical Professor\, Dr. Peter Phillips\, talk early days\, and what it was like treating the earliest cases of HIV. \nPlease register for the webinar by clicking the following link: \nCLICK HERE. \n*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars \nIf you have any questions regarding this event\, please contact BC-CfE’s Education and Training team at: education@bccfe.ca. \nDOWNLOAD POSTER PDF
URL:https://scienceinvancouver.com/event/bc-cfe-celebrates-30-years-of-excellence-6/
LOCATION:Online
END:VEVENT
END:VCALENDAR